Atlas Trials

A Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of TAK-828 Escalating Multiple-Doses in Healthy Participants

Clinical trial NCT02817516 · TERMINATED

Trial details

NCT number
NCT02817516
Sponsor
Takeda
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Volunteers
Start date
2016-06-30
Primary completion
2016-08-22
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.